I think this is once again an interesting name to buy back here...I recall timwest pointing it out in early 2016, near the very bottom before a huge rally. We were bullish on it at the right time, and I think it's the right time once again.
Fundamentals for the stock are a bit convoluted, with self diagnostic kits segment being highly competitive, and sales slumping, but the chart shows renewed interest in the stock from big buyers, given the accumulation base after a strong climb a month ago.
I would assume some interesting news is about to come out, that might be the catalyst to push it up from this base...
I'll be a buyer on signs of strength, if it breaks up from here soon.
Keeping an eye on it.
Cheers,
Ivan Labrie.
Fundamentals for the stock are a bit convoluted, with self diagnostic kits segment being highly competitive, and sales slumping, but the chart shows renewed interest in the stock from big buyers, given the accumulation base after a strong climb a month ago.
I would assume some interesting news is about to come out, that might be the catalyst to push it up from this base...
I'll be a buyer on signs of strength, if it breaks up from here soon.
Keeping an eye on it.
Cheers,
Ivan Labrie.
Note
So far so good, looks like we have caught the start of a move. Now it's a question of gauging follow through, when approaching resistance at 9.16.Note
OSUR trending still, the 3 day low was supported by strong buyers, trend is up.I'd be careful ahead of earnings by 6th Nov.
Trade closed manually
I took profits near the high on Friday, looking to rebuy after earnings maybe.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.